ExoDx Prostate Non-Invasive Test May Eliminate Unnecessary Prostate Biopsies, Study Says

ExoDx Prostate Non-Invasive Test May Eliminate Unnecessary Prostate Biopsies, Study Says
Exosome Diagnostics revealed positive clinical results evaluating its urine-based prostate cancer liquid biopsy test called ExoDx Prostate (IntelliScore). The study, “A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy,” published in JAMA Oncology, indicates the novel test could eliminate the need for tissue biopsies, supporting the value of investing in research targeting

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *